drugset / Trial / NCT01533597

The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)

NCT01533597

Phase 4 Completed 70 enrolled Soonchunhyang University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to investigate if the combination therapy consisting of anticholinergics plus alpha-blockers could be beneficial for women suffering from Overactive Bladder (OAB).

Timeline

Start
2010-12
Primary completion
2013-12
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Solifenacin Small molecule 5 mg Oral
Subject Tamsulosin Other / unclassified 0.2 mg Oral

Indications